1
|
Rahimi MR, Symonds ME. Effect of FTO genotype on exercise training and diet-indued weight loss in overweight and obese adults: a systematic review and meta-analysis. Crit Rev Food Sci Nutr 2024:1-17. [PMID: 39054902 DOI: 10.1080/10408398.2024.2382346] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/27/2024]
Abstract
Our meta-analysis, encompassing 30 studies with 46,976 subjects, aimed to explore the impact of fat mass and obesity-associated protein (FTO) genotypes on weight response to exercise and dietary interventions in overweight and obese adults. Electronic databases including PubMed and Google Scholar were searched from 2020 to September 2023 to identify relevant studies. Results revealed a significant reduction in body weight among individuals with the FTO risk allele following exercise and diet interventions (standardized mean difference [SMD] = - 0.619, 95% CI: - 1.137, - 0.100; p = .01). When examining FTO variants, both AA (SMD = - 0.148, 95% CI: - 0.282, - 0.014, p = .03, I2 = 24.96) and TA genotypes (SMD = - 0.674, 95% CI: - 1.162, - 0.186, p = .007, I2 = 91.12) showed significant weight reduction compared to the TT genotype. Moreover, individuals with the high-risk genotype AA + TT achieved greater weight loss compared to those with the normal-risk genotype TT (SMD = - 0.419, 95% CI: - 0.655, -0.183, p = .0001, I2 = 92.08) in the dominant genetic model. Subgroup analysis indicated that FTO risk allele carriers (AA + AT) with exercise interventions lasting six months and a body mass index of 25 - 29 experienced greater weight loss compared to TT carriers. These findings emphasize the importance of genetic considerations in weight management interventions and suggest personalized approaches for combating obesity. Further clinical trials are warranted to validate our study's findings.
Collapse
Affiliation(s)
| | - Michael E Symonds
- Academic Unit of Population and Lifespan Sciences, Centre for Perinatal Research, School of Medicine, University of Nottingham, Nottingham, UK
| |
Collapse
|
2
|
Evans C, Curtis J, Antonio J. FTO and Anthropometrics: The Role of Modifiable Factors. J Funct Morphol Kinesiol 2022; 7:jfmk7040090. [PMID: 36278751 PMCID: PMC9589926 DOI: 10.3390/jfmk7040090] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/05/2022] [Revised: 10/12/2022] [Accepted: 10/14/2022] [Indexed: 11/25/2022] Open
Abstract
Numerous gene variants are linked to an individual's propensity to become overweight or obese. The most commonly studied gene variant is the FTO single nucleotide polymorphism. The FTO risk allele is linked with increased body mass, BMI and other lifestyle factors that may perpetuate an individual's risk for obesity. Studies assessing eating behaviors, eating preferences, nutrition interventions and other lifestyle factors were reviewed. These studies demonstrated a clear difference in eating behaviors and preferences. Lifestyle modifications including physical activity and diet were effective in weight management even in those with the risk allele.
Collapse
Affiliation(s)
- Cassandra Evans
- Health and Human Performance, Nova Southeastern University, Davie, FL 33314, USA
- Healthy Sciences, Rocky Mountain University of Health Professions, Provo, UT 84606, USA
- Correspondence: ; Tel.: +1-954-709-4929
| | - Jason Curtis
- Exercise Science, Keiser University, West Palm Beach, FL 33411, USA
| | - Jose Antonio
- Health and Human Performance, Nova Southeastern University, Davie, FL 33314, USA
| |
Collapse
|
3
|
Wang W, Yang K, Wang S, Zhang J, Shi Y, Zhang H, Jin D, Gu R, Zeng Q, Hua Q. The sex-specific influence of FTO genotype on exercise intervention for weight loss in adult with obesity. Eur J Sport Sci 2021; 22:1926-1931. [PMID: 34478346 DOI: 10.1080/17461391.2021.1976843] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
The impact of exercise on weight loss varies significantly among individuals, and genes play a critical role. This study aims to explore whether the FTO gene variant (rs8050136) affects the influence of exercise on weight. The study initially recruited 240 Han Chinese adults with obesity, and 178 of them (101 men, 77 women, aged from 21 to 60) completed a 12-week moderate aerobic exercise programme. The participants were genotyped and obesity-related data were collected before and after the intervention. The intensity and the amount of exercise were precisely monitored. After the intervention, most obesity-related parameters of the participants showed a significant decrease. For muscle and lean body mass, significant change was only observed in males (P < 0.001) but not females (P = 0.205, P = 0.200 respectively). Importantly, for weight and BMI loss, we observed a genotype-by-gender interaction (P = 0.041, P = 0.042 respectively, adjusted for age, exercise time and baseline value). In the further analysis, after stratified for gender, the exercise-induced weight loss (P = 0.008), BMI loss (P = 0.010), muscle mass loss (P = 0.005) and lean body mass loss (P = 0.004) showed greater decrease in male subjects carrying at least one A allele compared to non-carriers. In conclusion, our study suggests that in Han Chinese population with obesity, carrying "obese risk gene" FTO (rs8050136) does not lead to the resistance to weight management intervention. More importantly, in male subjects, carrying FTO risk allele would even lose more weight than non-carriers after exercise intervention.Highlights For Han Chinese adults with obesity, carrying "obese risk gene" FTO could still achieve weight loss through exercise.Males carrying FTO risk allele would lose more weight than non-carriers after a 12-weeks exercise programme.
Collapse
Affiliation(s)
- Weimin Wang
- The Second Medical Center, Health Management Institute, Chinese PLA General Hospital, Beijing, People's Republic of China
| | - Ke Yang
- School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, People's Republic of China
| | - Shujie Wang
- Capital Bio Technology Co. Ltd, Beijing, People's Republic of China
| | - Jiani Zhang
- School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, People's Republic of China
| | - Yanyun Shi
- The Second Medical Center, Health Management Institute, Chinese PLA General Hospital, Beijing, People's Republic of China
| | - Huawei Zhang
- School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, People's Republic of China
| | - Danping Jin
- Capital Bio Technology Co. Ltd, Beijing, People's Republic of China
| | - Ruoxi Gu
- School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, People's Republic of China
| | - Qiang Zeng
- The Second Medical Center, Health Management Institute, Chinese PLA General Hospital, Beijing, People's Republic of China
| | - Qian Hua
- School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, People's Republic of China
| |
Collapse
|
4
|
Schupfner R, Pecher S, Pfeifer E, Stumpf C. Physiological factors which influence the performance potential of athletes: analysis of sports medicine performance testing in Nordic combined. PHYSICIAN SPORTSMED 2021; 49:106-115. [PMID: 32662310 DOI: 10.1080/00913847.2020.1796181] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
BACKGROUND The sports medicine performance diagnostics include investigative procedures that supply information on the performance capacity and stamina of an athlete. This creates a foundation for a personalised training plan and enables optimised control of the training process. METHODOLOGY The study population consisted of 24 male Nordic combined athletes from the national German squad. They were monitored using sports medicine over a period of five winter seasons. The test speeds on the treadmill in m/s are determined at lactate values of 2, 3 and 4 mmol/l in the peripheral blood values to calculate the lactate curve. RESULTS The higher the test performance expressed as a percentage, the more likely it was that a top position could be achieved. The individual anaerobic threshold and the maximal oxygen uptake increased significantly with an increase in test performance expressed as a percentage. The older the athlete, the better they performed in the overall world cup. When age increased, the test speed [m/s] at lactate values of 2, 3 and 4 mmol/l also increased, along with the test performance expressed as a percentage, the maximal oxygen uptake and the individual anaerobic threshold. A higher BMI proved advantageous in terms of placement in the individual competitions. CONCLUSION In this study the test speed at a lactate concentration of 4 mmol/l can be recommended as a robuster, more independent from mathematical models and physiologically more valid parameter for performance diagnostics in professional athletes.
Collapse
Affiliation(s)
- Rupert Schupfner
- Department of Traumatology, Hospital Bayreuth , Bayreuth, Germany
| | - Stefan Pecher
- Department of Sports Medicine, DOSB Frankfurt am Main , Germany
| | - Eva Pfeifer
- Department of Traumatology, Hospital Bayreuth , Bayreuth, Germany
| | | |
Collapse
|
5
|
Antonio J, Knafo S, Kapoor R, Tartar JL. A fat mass and obesity-associated gene polymorphism influences fat mass in exercise-trained individuals. J Int Soc Sports Nutr 2018; 15:40. [PMID: 30124167 PMCID: PMC6102834 DOI: 10.1186/s12970-018-0246-7] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/26/2018] [Accepted: 08/01/2018] [Indexed: 12/04/2022] Open
Abstract
Background A single nucleotide polymorphism (SNP) in the fat mass and obesity-associated (FTO) gene is a strong predictor of obesity in humans. The FTO SNP (rs1421085) results in a T to C nucleotide substitution that may result in an increased risk for obesity in individuals who carry at least one C allele. The purpose of this investigation was to characterize the FTO genotype in a cohort of exercise-trained men and women. Methods We tested 108 exercise-trained individuals that included professional mixed martial arts fighters, competitive distance runners, collegiate swimmers, stand-up paddlers as well as a cohort of recreational bodybuilders. Body composition was assessed via dual-energy x-ray absorptiometry (DXA). Saliva samples were collected in order to genotype participants and quantify cortisol levels. Results The physical characteristics of the subjects were as follows (mean±SD): body weight 74.5±15.6 kg; height 171.5±9.5 cm; bone mineral content 2.8±0.7 kg; fat mass 15.7±5.5 kg; lean body mass 55.9±14.4 kg; % body fat 21.6±7.0. Independent samples t tests showed that C allele carriers (n = 54) had significantly higher fat mass t(106) = 3.13, p < 0.01 and body fat percentage t(106) = 2.68, p < 0.01, relative to the TT group (n = 54) (i.e., fat mass: C/− 17.3 ±5.6 kg, TT 14.2±4.6 kg; body fat percentage: C/− group 23.4±7.4%, TT group 19.9±6.2). No other measures of body composition were associated with the FTO genotype (i.e., body mineral density, bone mineral content, or lean body mass). Moreover, cortisol levels were significantly higher in the TT group relative to the C allele carriers t(106) = 2.37, p = 0.02 (i.e., TT 0.35 ±0.35 μg/dL, C/− 0.22±0.16 μg/dL). Conclusions Our findings demonstrate a relationship between C allele carriers on the FTO gene and a predisposition to a higher fat mass and body fat percentage. In addition, we found no relationship between cortisol and fat mass. However, due to the cross-sectional nature of this investigation, we cannot infer causality regarding the FTO gene and body composition.
Collapse
Affiliation(s)
- Jose Antonio
- Department of Health and Human Performance, Nova Southeastern University, 3401 South University Drive, Davie, FL, 33328, USA.
| | - Sarah Knafo
- Department of Psychology and Neuroscience, Nova Southeastern University, Davie, FL, USA
| | - Ritishka Kapoor
- Department of Psychology and Neuroscience, Nova Southeastern University, Davie, FL, USA
| | - Jaime L Tartar
- Department of Psychology and Neuroscience, Nova Southeastern University, Davie, FL, USA
| |
Collapse
|
6
|
Wagner R, Tabák ÁG, Fehlert E, Fritsche L, Jaghutriz BA, Bánhegyi RJ, Schmid SM, Staiger H, Machicao F, Peter A, Häring HU, Fritsche A, Heni M. Excessive fuel availability amplifies the FTO-mediated obesity risk: results from the TUEF and Whitehall II studies. Sci Rep 2017; 7:15486. [PMID: 29138452 PMCID: PMC5686126 DOI: 10.1038/s41598-017-15744-4] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2017] [Accepted: 10/31/2017] [Indexed: 11/23/2022] Open
Abstract
Variation in FTO is the most important common genetic determinant of body weight. Altered energy metabolism could underlie this association. We hypothesized that higher circulating glucose or triglycerides can amplify the FTO impact on BMI. In 2671 subjects of the TUEF study, we investigated the interaction effect of fasting glucose and triglyceride levels with rs9939609 in FTO on BMI. We analysed the same interaction effect by longitudinally utilizing mixed effect models in the prospective Whitehall II study. In TUEF, we detected an interaction effect between fasting glucose and fasting triglycerides with rs9939609 on BMI (p = 0.0005 and p = 5 × 10−7, respectively). The effect size of one risk allele was 1.4 ± 0.3 vs. 2.2 ± 0.44 kg/m² in persons with fasting glucose levels below and above the median, respectively. Fasting triglycerides above the median increased the per-allele effect from 1.4 ± 0.3 to 1.7 ± 0.4 kg/m2. In the Whitehall II study, body weight increased by 2.96 ± 6.5 kg during a follow-up of 13.5 ± 4.6 yrs. Baseline fasting glucose and rs9939609 interacted on weight change (p = 0.009). Higher fasting glucose levels may amplify obesity-risk in FTO carriers and lead to an exaggerated weight gain over time. Since weight gain perpetuates metabolic alterations, this interplay may trigger a vicious circle that leads to obesity and diabetes.
Collapse
Affiliation(s)
- Róbert Wagner
- Department of Internal Medicine IV, Division of Endocrinology, Diabetology, Nephrology, Vascular Disease and Clinical Chemistry, University Hospital of Tübingen, Tübingen, Germany.,Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen (IDM), Tübingen, Germany.,German Center for Diabetes Research (DZD), Neuherberg, Germany
| | - Ádám G Tabák
- Department of Epidemiology and Public Health, University College London, London, UK.,1st Department of Medicine, Semmelweis University Faculty of Medicine, Budapest, Hungary
| | - Ellen Fehlert
- Department of Internal Medicine IV, Division of Endocrinology, Diabetology, Nephrology, Vascular Disease and Clinical Chemistry, University Hospital of Tübingen, Tübingen, Germany.,Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen (IDM), Tübingen, Germany.,German Center for Diabetes Research (DZD), Neuherberg, Germany
| | - Louise Fritsche
- Department of Internal Medicine IV, Division of Endocrinology, Diabetology, Nephrology, Vascular Disease and Clinical Chemistry, University Hospital of Tübingen, Tübingen, Germany.,Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen (IDM), Tübingen, Germany.,German Center for Diabetes Research (DZD), Neuherberg, Germany
| | - Benjamin A Jaghutriz
- Department of Internal Medicine IV, Division of Endocrinology, Diabetology, Nephrology, Vascular Disease and Clinical Chemistry, University Hospital of Tübingen, Tübingen, Germany.,Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen (IDM), Tübingen, Germany.,German Center for Diabetes Research (DZD), Neuherberg, Germany
| | | | - Sebastian M Schmid
- German Center for Diabetes Research (DZD), Neuherberg, Germany.,Department of Internal Medicine I, Division of Endocrinology, Diabetology, and Metabolism, University Hospital of Lübeck, Lübeck, Germany
| | - Harald Staiger
- Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen (IDM), Tübingen, Germany.,German Center for Diabetes Research (DZD), Neuherberg, Germany.,Interfaculty Centre for Pharmacogenomics and Pharma Research at the Eberhard Karls University Tübingen, Tübingen, Germany.,Institute of Pharmaceutical Sciences, Department of Pharmacy and Biochemistry, Eberhard Karls University Tübingen, Tübingen, Germany.,Institute of Experimental Genetics, Helmholtz Centre Munich, German Research Center for Environmental Health, Neuherberg, Germany
| | - Fausto Machicao
- Institute of Experimental Genetics, Helmholtz Centre Munich, German Research Center for Environmental Health, Neuherberg, Germany
| | - Andreas Peter
- Department of Internal Medicine IV, Division of Endocrinology, Diabetology, Nephrology, Vascular Disease and Clinical Chemistry, University Hospital of Tübingen, Tübingen, Germany.,Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen (IDM), Tübingen, Germany.,German Center for Diabetes Research (DZD), Neuherberg, Germany
| | - Hans-Ulrich Häring
- Department of Internal Medicine IV, Division of Endocrinology, Diabetology, Nephrology, Vascular Disease and Clinical Chemistry, University Hospital of Tübingen, Tübingen, Germany.,Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen (IDM), Tübingen, Germany.,German Center for Diabetes Research (DZD), Neuherberg, Germany
| | - Andreas Fritsche
- Department of Internal Medicine IV, Division of Endocrinology, Diabetology, Nephrology, Vascular Disease and Clinical Chemistry, University Hospital of Tübingen, Tübingen, Germany.,Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen (IDM), Tübingen, Germany.,German Center for Diabetes Research (DZD), Neuherberg, Germany
| | - Martin Heni
- Department of Internal Medicine IV, Division of Endocrinology, Diabetology, Nephrology, Vascular Disease and Clinical Chemistry, University Hospital of Tübingen, Tübingen, Germany. .,Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Centre Munich at the University of Tübingen (IDM), Tübingen, Germany. .,German Center for Diabetes Research (DZD), Neuherberg, Germany.
| |
Collapse
|